Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Unravelling the underpinnings of hyperprogression and immunotherapy: back to the bench

Oncotarget(2021)10.18632/oncotarget.28098Source: DataRank Database

Unravelling the underpinnings of hyperprogression and immunotherapy: back to the bench is a research paper published in Oncotarget (2021). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: goldTopics (8)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Razelle Kurzrock ORCID,Vivek Subbiah ORCID

Live enrichment

PubMed:35018215 PMC:PMC8730288

National Institutes of Health

Grant: 5U01CA180964-02

Informatics to enable routine personalized cancer therapy

National Institutes of Health

Grant: 4UL1TR000371-10

Center for Clinical and Translational Sciences (CCTS)

National Institutes of Health

Grant: 5R01CA242845-04

Blocking tumor progression in therapy-responsive RET aberration-associated cancer

National Institutes of Health

Grant: 3P30CA016672-41S4

Cancer Center Support (CORE) Grant

goldLicense: http://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

publisherhttps://www.oncotarget.com/lookup/doi/10.18632/oncotarget.28098

Europe_PMChttps://europepmc.org/articles/PMC8730288

Europe_PMChttps://europepmc.org/articles/PMC8730288?pdf=render

https://doi.org/10.18632/oncotarget.28098

https://pubmed.ncbi.nlm.nih.gov/35018215

Fields of Study

03 medical and health sciences0302 clinical medicine

Keywords

ImmunotherapyPD-1checkpointMouse ModelHyperprogressionEditorial